Grifols reported EUR3.56B in Stock for its fiscal quarter ending in December of 2024.





Stock Change Date
aTyr Pharma USD 2.86M 126.59K Sep/2025
Cara Therapeutics USD 900K 0 Mar/2025
Esperion Therapeutics USD 108.54M 5.93M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Grifols EUR 3.56B 63.19M Dec/2024
Infinity Pharmaceuticals USD 0 0 Sep/2021
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
TherapeuticsMD USD 6.7M 551K Sep/2022